Innovation in the cloud: see what artificial intelligence can do for ICMs

This presentation will summarize the state-of-the-art in transporters in drug development based on four recent ITC3 whitepapers (Clin Pharmacol Ther 104, October 2018). Practical overview of emerging transporters of clinical relevance will be provided (e.g., OCT1, OATP2B1, etc.). Best practice in design of clinical DDI studies will be illustrated with recent advances in the study of OCT1, P-gp, and BCRP. Considerations for optimal selection of clinical probe drugs, including future potential utility of transporter biomarkers, also will be discussed.

The webinar will focus on the relationship between analytics of biotherapeutic products and the interpretation of data to build and support a solid regulatory Chemistry, Manufacturing and Control (CMC) strategy. The importance of data interpretation is illustrated in the development of biosimilars and new biological entities, as well as in regulatory specifications regarding biotherapeutic products.

Our 4th Annual Microbiology and Immunology Virtual Conference is now available On Demand! Participants will explore and discover new concepts, tools and techniques to apply to ongoing research and diagnostics. Microbiology and Immunology cover an array of industries and disciplines, encompassing various research areas including pharmaceuticals, medicine, agriculture, and space. The development of new techniques and the ability to sequence organisms without the need to grow them in the laboratory has opened up a new world of microbial diversity and complexity we know little about.

In this insightful webinar, our panel of industry leading experts explore how to plan for the successful development of new cell therapies using emerging raw materials and technologies.